Bioventix PLC
BVXP.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.93 | -7.57 | 2.52 | 1.68 |
| FCF Yield | 4.88% | 3.65% | 3.93% | 4.20% |
| EV / EBITDA | 13.62 | 20.70 | 19.11 | 18.42 |
| Quality | ||||
| ROIC | 64.41% | 67.61% | 68.85% | 64.61% |
| Gross Margin | 90.86% | 93.20% | 92.53% | 92.71% |
| Cash Conversion Ratio | 0.93 | 1.03 | 0.94 | 0.99 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.77% | 5.10% | 5.45% | 4.35% |
| Free Cash Flow Growth | -15.80% | 5.52% | 4.54% | 23.61% |
| Safety | ||||
| Net Debt / EBITDA | -0.50 | -0.56 | -0.56 | -0.65 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 30,605.69 |
| Efficiency | ||||
| Inventory Turnover | 1.74 | 1.50 | 1.69 | 1.85 |
| Cash Conversion Cycle | 359.91 | 342.21 | 351.46 | 292.91 |